Biotic/Abiotic Stress-Driven Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OPINION article Front. Cell. Neurosci., 23 November 2016Sec. Non-Neuronal Cells Volume 10 - 2016 | https://doi.org/10.3389/fncel.2016.00269
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009505 · Cited by 1,060 · cited 1×
“In contrast to the conventional assertion of a causative role of Aβ in AD pathogenesis, the peptide was surprisingly recognized as an antimicrobial peptide (AMP) with potent activity against pathogenic infections (Soscia et al., 2010).”
BackgroundKumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971 · cited 2×
“It was suggested that tau phosphorylation at later stages is mostly a consequence of hypothermia although hyperphosphorylation at early stages may be due to the deregulation of JNK and PP2A (El-Khoury et al., 2016).”
Apolipoprotein E in Alzheimer’s disease and other neurological disorders
Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70325-2 · Cited by 857 · cited 1×
“Evidence supporting a possible infectious origin of AD is also derived from the sequencing-classified single nucleotide polymorphism (SNP) in apolipoprotein E gene (APOE), which is involved in modulating the immune response and infectious susceptibility (Verghese et al., 2011).”
BackgroundLiu, S.-Y., Aliyari, R., Chikere, K., Li, G., Marsden, M. D., Smith, J. K., Pernet, O., Guo, H., Nusbaum, R., Zack, J. A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.11.005 · Cited by 678
Minter, M. R., Zhang, C., Leone, V., Ringus, D. L., Zhang, X., Oyler-Castrillo, P., Musch, M. W., Liao, F., Ward, J. F., Holtzman, D. M., et al. (2016) · Scientific Reports · doi:10.1038/srep30028 · Cited by 655 · cited 2×
“It was suggested that tau phosphorylation at later stages is mostly a consequence of hypothermia although hyperphosphorylation at early stages may be due to the deregulation of JNK and PP2A (El-Khoury et al., 2016).”
Microbes and Alzheimer’s Disease
Itzhaki, R. F., Lathe, R., Balin, B. J., Ball, M. J., Bearer, E. L., Braak, H., Bullido, M. J., Carter, C., Clerici, M., Cosby, S. L., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160152 · Cited by 532
Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain
Balin, B. J., Gérard, H. C., Arking, E. J., Appelt, D. M., Branigan, P. J., Abrams, J. T., Whittum-Hudson, J. A., & Hudson, A. P. (1998) · Medical Microbiology and Immunology · doi:10.1007/s004300050071 · Cited by 506 · cited 1×
“…plaques; SRB, sulfate-reducing bacteria; SNP, single-nucleotide polymorphism; TGF, transforming growth factor; TLR4, toll-like receptor 4. pneumoniae (Balin et al., 1998), Helicobacter pylori (Kountouras et al., 2012), Toxoplasma gondii (Prandota, 2014), human immunodeficiency virus (HIV;…”
BackgroundAlzheimer’s disease and gut microbiota
Hu, X., Wang, T., & Jin, F. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5083-9 · Cited by 371
Zhang, R., Miller, R. G., Gascon, R., Champion, S., Katz, J., Lancero, M., Narvaez, A., Honrada, R., Ruvalcaba, D., & McGrath, M. S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.017 · Cited by 319 · cited 2×
“…diseases include: the plasma level of LPS in patients with neurodegenerative disease is three times higher than in healthy persons (Zhang et al., 2009); and intraperitoneal injections of LPS into mice cause a prolonged elevation hippocampal Aβ levels and lead to cognitive deficits…”
BackgroundLessons from a failed γ-secretase Alzheimer trial
De Strooper, B. (2014) · Cell · doi:10.1016/j.cell.2014.10.016 · Cited by 277
Cox, P. A., Davis, D. A., Mash, D. C., Metcalf, J. S., & Banack, S. A. (2016) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2015.2397 · Cited by 256
Bourgade, K., Garneau, H., Giroux, G., Le Page, A. Y., Bocti, C., Dupuis, G., Frost, E. H., & Fülöp, T. (2015) · Biogerontology · doi:10.1007/s10522-014-9538-8 · Cited by 208
Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS
Yamamoto, Y., Harashima, A., Saito, H., Tsuneyama, K., Munesue, S., Motoyoshi, S., Han, D., Watanabe, T., Asano, M., Takasawa, S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002253 · Cited by 207 · cited 1×
“To trigger AD, biotic stressors convey the external biological signals via lipopolysaccharide (LPS)-toll-like receptor 4 (TLR4), LPS-receptor of advanced glycation end products (RAGE), and amyloid β peptide (Aβ)/senile plaques (SP)-RAGE interactions (Yan et al., 1996; Yamamoto et al., 2011).”
BackgroundPorphyromonas gingivalis Periodontal Infection and Its Putative Links with Alzheimer’s Disease
Singhrao, S. K., Harding, A., Poole, S., Kesavalu, L., & Crean, S. (2015) · Mediators of Inflammation · doi:10.1155/2015/137357 · Cited by 195 · cited 2×
“…infectious pathogens were also considered as AD triggers; for example, oral pathogenic infections by the periodontal bacteria Porphyromonas gingivalis and Actinomyces naeslundii were identified as high-risk factors driving development toward AD (Noble et al., 2014; Singhrao et al., 2015).”
BackgroundWhite, M. R., Kandel, R., Tripathi, S., Condon, D., Qi, L., Taubenberger, J., & Hartshorn, K. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101364 · Cited by 193 · cited 2×
“Aβ was also found to possess antiviral activity against HSV-1 and influenza A (White et al., 2014; Bourgade et al., 2015, 2016).”
Kahn, M. S., Kranjac, D., Alonzo, C. A., Haase, J. H., Cedillos, R. O., McLinden, K. A., Boehm, G. W., & Chumley, M. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.010 · Cited by 177 · cited 1×
“…include: the plasma level of LPS in patients with neurodegenerative disease is three times higher than in healthy persons (Zhang et al., 2009); and intraperitoneal injections of LPS into mice cause a prolonged elevation hippocampal Aβ levels and lead to cognitive deficits (Kahn et al., 2012).”
BackgroundBourgade, K., Le Page, A., Bocti, C., Witkowski, J. M., Dupuis, G., Frost, E. H., & Fülöp, T. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150652 · Cited by 161 · cited 1×
“Aβ was also found to possess antiviral activity against HSV-1 and influenza A (White et al., 2014; Bourgade et al., 2015, 2016).”
BackgroundLurain, N. S., Hanson, B. A., Martinson, J., Leurgans, S. E., Landay, A. L., Bennett, D. A., & Schneider, J. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit210 · Cited by 159
Brenner, S. R. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2012.10.010 · Cited by 107 · cited 1×
“Cyanobacteria or blue-green algae residing in the gut may produce the neurotoxin β-N-methylamino-L-alanine (BMAA), which was implicated in the development of AD (Banack et al., 2010; Brenner, 2013).”
Background
Cited by
Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Kowalski, K., & Mulak, A. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18087 · Cited by 826
“Excessive microglial stimulation and increased neuroinflammatory signaling through NF-κB, proinflammatory cytokines and reactive oxidative and nitrosative stressors lead to neuronal and glial cell death.(62) Another consequence of neuroinflammation is downregulation of triggering receptor expressed on myeloid cells 2”
BackgroundRole of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease
Kesika, P., Suganthy, N., Sivamaruthi, B. S., & Chaiyasut, C. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118627 · Cited by 479
Zhao, Y., Jaber, V., & Lukiw, W. J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00318 · Cited by 379
Mancuso, C., & Santangelo, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.009 · Cited by 232
Gut microbiota, cognitive frailty and dementia in older individuals: A systematic review
Ticinesi, A., Tana, C., Nouvenne, A., Prati, B., Lauretani, F., & Meschi, T. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s139163 · Cited by 215
Metadata
- Authors
- Li, C.-Q., Zheng, Q., Wang, Q., & Zeng, Q.-P.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2016-11-23
- Volume
- 10
- Pages
- 269-269
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2553897814
- Cited by
- 32
- References
- 22
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.